Exploring the Role of Berberine and Probiotics in Managing Type 2 Diabetes
[vc_row css_animation="element_from_fade" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="center" background_image_as_pattern="without_pattern" padding_bottom="0" z_index="" css=".vc_custom_1533794039349{margin-bottom: 0px !important;border-bottom-width: 0px !important;padding-bottom: 0px !important;}"][vc_column][vc_column_text css=""] Exploring the Role of Berberine and Probiotics in Managing Type 2 Diabetes Insights from the PREMOTE Study [/vc_column_text][vc_row_inner row_type="row" type="grid" text_align="left" css_animation="" background_color="#ffffff" css=".vc_custom_1534244134279{margin-bottom: 0px !important;border-bottom-width: 0px !important;padding-bottom: 60px !important;}"][vc_column_inner css=".vc_custom_1534244647194{margin-top: -10% !important;padding-right: 50px !important;padding-left: 50px !important;}"][vc_empty_space][vc_single_image image="74935" img_size="full" alignment="center" css=".vc_custom_1741740138248{padding-right: 10% !important;padding-left: 10% !important;}" qode_css_animation="" qode_hover_animation="zoom_in"][vc_empty_space height="20px"][vc_column_text css=""] The complex interplay between gut microbiota and metabolic diseases has gained significant attention in recent years. The PREMOTE study (Probiotics and BBR on the Efficacy and Change of Gut Microbiota in Patients with Newly Diagnosed Type...